chrisvoncsefalvay/vaers-outcomes huggingface dataset:
started running a fever of 100-1; was lethargic; had flu-like symptoms; began coughing at 48 hours post vaccine; pain in chest once cough appeared; This is a spontaneous report from a contactable consumer (patient) reported for himself that. A 14-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 06Jul2021 17:30 (Batch/Lot Number: EW0198) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccination. The patient has not received other medications in two weeks. The patient is a pediatric dentist, so he trained in the field of health care. Approximately, 24 hours of 2nd vaccine, patient started running a fever of 100-101, continued to run fever for 5 days and began lethargic had flu-like symptoms and coughing at 48 hours post vaccine. Patient reported pain in chest once cough appeared on 07Jul2021 Cough lasted 11 days. Patient continued to have lethargy for 9 days post vaccine. At day 4, spoke to pediatrician re: symptoms. The patient is a pediatric dentist, so he trained in the field of health care. Approximately, 24 hours of 2nd vaccine. On 07Jul2021 approximately, 24 hours of 2nd vaccine, patient started running a fever of 100-101. Patient was lethargic and had flu-like symptoms. Patient was given Motrin to help with symptoms. Patient continued to run fever for 5 days. Patient began coughing at 48 hours post vaccine. Patient reported pain in chest once cough appeared. Cough lasted 11 days. Patient continued to have lethargy for 9 days post vaccine. At day 4, spoke to pediatrician re: symptoms. The patient underwent lab tests and procedures which included body temperature: 100-101 on 07Jul2021, chest x-ray: normal on 12Jul2021 At day 6, a chest X-ray was taken and it was normal, echocardiogram: normal on 16Jul2021 At day 10 an echo was done on patient and it was found to be normal , mononucleosis heterophile test: Negative on 13Jul2021 At day 7 patient was evaluated by physician and tested negative for COVID and mono , sars-cov-2 antibody test: negative on 13Jul2021. The events result in doctor or other healthcare professional office/clinic visit. The event outcome was recovered on unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a nurse and refers to a male patient of unknown age. No information regarding the patients' medical history and concurrent conditions was provided. On unknown dates, the patient were vaccinated with improperly stored dose of PNEUMOVAX 23 injection, lot number N037533, expiration date: 17-MAY-2018 (exact dose, route of administration were not provided) for prophylaxis. There were no concomitant medications reported. The reporter stated, that the vaccines were subject to temperatures excursion of 47 degrees Fahrenheit to 77 degrees Fahrenheit for 29 minutes. The temperature excursion was captured using digital data logger. It was also reported, that the vaccines underwent previous temperature excursion of 47 degrees Fahrenheit to 77 degrees Fahrenheit for 9 hours on unspecified dates. No adverse effects were reported. Additional information has been requested. Sender's Comments: US-009507513-1805USA001642: US-009507513-1805USA001643: US-009507513-1805USA001645: US-009507513-1805USA001646: US-009507513-1805USA001647: US-009507513-1710USA011550.
Immune thrombocytopenia, platelet count of 1,000, also with intraventricular hemorrhage. Presented to Urgent Care on 1/22/22 with petechiae and bleeding. Then came to ED @ Hospital 1/24/22, platelet count 1, treated with  IVIG and high dose steroids. CT head and MRI head noted to have bleeding in ventricle.
Pain at the injection site started about 4 hours after the vaccine was administered. Approximately 11 hours after administration chills and fever started. Fever of 103.5 remained for the next 10 hours.  Acetaminophen was taken and fever reduced to 101.5. Fever remained for the next 12 hours. Dizziness started on day two after vaccine.
Eyes itching, throat swelling,  tongue thickness, facial swelling & itching on 5/06/21 On 5/08/21, approx 4:30pm. Wave of pain top of neck spread over my head. Immediately throat swelling, tongue thickening,  slurred speech, left side face numbness & tingling. Called 9-1-1. Approx 3:30 am, wave of heat over my head; face & left arm felt so heavy like I couldn't move. Numbness to left face, eye & my tongue. There has been and continues to be a metallic taste in my mouth.
PT said she has an immediate reaction to the vaccine and she experienced hot flashes, her chest felt heavy and her head felt light; PT said she has an immediate reaction to the vaccine and she experienced hot flashes, her chest felt heavy and her head felt light; PT said she has an immediate reaction to the vaccine and she experienced hot flashes, her chest felt heavy and her head felt light; This is a spontaneous report from a contactable consumer or other non hcp (patient) received from Pfizer sponsored program COVAX US Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on Feb2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Feb2021, the patient experienced an immediate reaction to the vaccine and she experienced hot flashes, her chest felt heavy and her head felt light. Patient was asking if it is advisable to take the second dose. The outcome of the events was unknown.  Information on lot/batch number was requested.
she took the band aid off this morning and noticed a white circle an inch below where the injection was given and there is a tiny "pucker" mark in the middle of the white circle; Initial information received on 02-Nov-2023 (processed as non-case) and additional information on 03-Nov-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (non-healthcare professional).  This case involves 68 years old female patient who took the band aid off this morning and noticed a white circle an inch below where the injection was given and there is a tiny "pucker" mark in the middle of the white circle after receiving influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 01-Nov-2023, the patient received a dose of suspect influenza quadrival A-B high dose HV vaccine (strength, formulation, dosage, lot number, expiry date- not reported) via unknown route in unknown administration site for prophylactic vaccination (Immunisation). Information on the batch number was requested.  On 02-NOV-2023, the patient took the band aid off this morning and noticed a white circle an inch below where the injection was given and there is a tiny "pucker" mark in the middle of the white circle (vaccination site reaction) (latency- 1 day) following the administration of influenza quadrival A-B high dose HV vaccine.  Reportedly, Caller says that she noticed that there was a different delivery system for the injection. Caller wants to know if the white mark is common with the new delivery system.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
66 yo community member, throat tightness & nausea post vaccination, 911 to ED feeling fine at arrival, pt chose to leave & encouraged to follow up  with ED or PCP if any further issues
Patient started having  an electrical feeling/chest pain. She went to see her doctor and he diagnosed her with cardiomyopathy.
This person began developing side effects later in the evening on the day of the vaccination.  She developed low grade fever, red inflamed arm, intense nausea and reflux, and weakness.  She went to the ER and was treated for her symptoms.
Swollen under arm lymph nodes, as big as 1/2 tennis ball size, mild pain
I experienced significant ear ringing about nine hours after the injection and this has continued though it seems worse certain times of the day and night. The intensity of the ear ringing varies throughout the day and night.
Within minutes of getting a cortisone shot in my wrist, I felt pressure in my head and face, nausea, and chills. The pressure and nausea went away in about 20 minutes.  I got home and took a nap, falling asleep about an hour after the injection. the chills worsened until I was asleep. I was awakened by the phone three hours later (four hours after the injection) feeling fine
Swelling of face - around both eyes, right cheek, right jawline, right ear lobe; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Sep2021 14:30 (Lot number: 301458A) at the age of 74 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "hypercholesteremic" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; ATORVASTATIN; CENTRUM SILVER WOMEN 50+. The following information was reported: SWELLING FACE (non-serious) with onset 27Sep2021 14:30, outcome "not recovered", described as "Swelling of face - around both eyes, right cheek, right jawline, right ear lobe". Therapeutic measures were taken as a result of swelling face treatment with diphenhydramine self-administered.  Additional Information: No other vaccine in four weeks. Facility type Vaccine was Pharmacy or Drug Store. No Covid prior vaccination. Covid not tested post vaccination. No known allergies.  No follow-up attempts are possible. No further information is expected.
Painful rash x 2 days LT. T9 distribution above umbilicus. TX Valtrex (1gram tid x 7 days) Calamine lotion.
itching and hives begin 24-30 hours post administration of vaccine, lip swelling 10/16/20, began taking Benedryl PO 10/15/20. Has continued with daily Zertec. Itching and hives are generalized over entire body. Itching seems a little better 10/25 and 10/26, hives are continuing.
Pt recvd 2 doses of Hep B vax; 2nd dose on 25JAN91; About 9PM evening of vax  pt became febrile temp varied between 99-103 & was extremely weak; 28JAN91 seen by MD who believed problem was due to Hep B vax; No treatment given;
5/28/21: Dose 1 given in error was  Moderna 7/2/21: Dose 2 was to be with Moderna and Pfizer was given
This is a spontaneous report by a contactable consumer. This female reporter called on behalf of her son who received PREVNAR 13 unknown dose for an unknown reason on an unknown date. Relevant medical history was unknown. Relevant concomitant medications were unknown. In Feb2011 while on PREVNAR 13 her son was not sleeping well and eating like before. Relevant lab data was unknown. At the time of the report it was unknown if her son was taking PREVNAR 13. At time of the report he had not recovered from the above mentioned events.
This spontaneous report as received from a registered nurse refers to multiple patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored with VARIVAX, injection, lot # L017146, expiry date 13-MAY-2017 and lot # L035127, expiry date 14-SEP-2017 (dose, route and site of administration were not reported). No adverse were reported. This is one of two reports received from the same source. Additional information has been requested.
38 y.o. female who had concerns including Rash (Acute Visit).   HPI She has a CoVId vaccine 1/11 and has a rash on left arm. Itching. Has put a cold compress on arm. Some nausea, headache, dizziness yesterday. Rash started 1 week after injection. Warm to touch yesterday  Patient Active Problem List Diagnosis ? Alport syndrome ? Depressive disorder ? Underweight ? Tobacco abuse      Outpatient Medications Marked as Taking for the 1/21/21 encounter (Office Visit) with APRN Medication Sig ? oxycodone-acetaminophen (PERCOCET) 5-325 MG Take 1 tablet by mouth every 8 (eight) hours as needed for Moderate Pain. Do not exceed a daily dose of 3 tablets      Allergies Allergen Reactions ? Metronidazole Rash ? Morphine Hives and Rash     Patient's medications, allergies, past medical, histories were reviewed and updated as appropriate.     ROS: Negative ROS except for those pertinent positive symptoms as listed above in HPI.      Objective    Vitals Vitals:   01/21/21 1504 BP: 114/64 BP Location: Left arm Patient Position: Sitting Cuff Size: Regular Adult Pulse: 72 Resp: 14 Temp: 99 °F (37.2 °C) TempSrc: Temporal SpO2: 98% Weight: 99 lb 14.4 oz (45.3 kg) Height: 5' 2" (1.575 m)    Body mass index is 18.27 kg/m².   Physical Exam Constitutional:      Appearance: She is well-developed.  HENT:     Head: Normocephalic.  Eyes:     General: Lids are normal.     Conjunctiva/sclera: Conjunctivae normal.  Neck:     Musculoskeletal: Normal range of motion.     Trachea: Trachea normal.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds.  Abdominal:     General: Bowel sounds are normal.     Tenderness: There is no abdominal tenderness.  Skin:    General: Skin is warm and dry.     Comments: Left upper arm as below  Neurological:     Mental Status: She is alert and oriented to person, place, and time.  Psychiatric:        Speech: Speech normal.               Assessment/Plan    1. Adverse effect of vaccine, initial encounter Comments: will try topical steroid think related to vaccine Orders: -     triamcinolone (KENALOG) 0.1 % cream; Apply topically 2 (two) times daily.   2. Laboratory exam ordered as part of routine general medical examination -     CBC and differential; Future -     Comprehensive metabolic panel; Future -     Lipid panel; Future       Return for March for physical.     APRN Electronically Signed 1/21/2021 3:30 PM
Pfizer-BioNTech COVID- 19 Vaccine EUA EMS states "Pt received 1st covid vaccine dose at the clinic. Had an anaphylactic reaction, SOB, throat swelled, abdominal cramps. Received epi injection and 25mg benadryl. BP 150/70. Was tachycardic but HR currently in the 90's." Patient reports similar reaction when she received an allergy shot. ED Physician Note: "She was given her injection and then within about 2 minutes felt palpitations, lightheadedness, whole body numbness, an odd tongue sensation, and stomach cramping. She was given epinephrine and benadryl" Patient was discharged from ED same day with resolution of symptoms.
never got her 2nd dose due to Covid; This non-serious case was reported by a consumer and described the occurrence of social problem in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on October 2021, in right arm).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced social problem (Verbatim: I got my first shingles shot but didn't get back for my second within time, do I start over/she received her 1st dose of Shingrix around October 2021 (no specific date provided), and never got her 2nd dose due to Covid).  The outcome of the social problem was unknown.   Additional Information: GSK receipt date: 19-Aug-2023 and 21-Aug-2023 The patient was not sure who administered the vaccine. The patient did not have any lot and expiry date. The patient received 1st dose and never get 2nd dose due to Covid, which led to social problem.  The patient was not asked for the follow up with the health care professional (HCP).
booster doses administered after expiration date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date). On 17-Nov-2021, EXPIRED PRODUCT ADMINISTERED (booster doses administered after expiration date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.            No treatment information was provided.
Vomiting, nausea, dehydration, confusion, malaise. Went to hospital ER the evening of 4/16/21 and was administered IV fluids and anti-emetics. Left ER early the following morning
Severe arm pain, severe myalgia and arthralgias, severe back pain, dizziness, sweats, weakness, fatigue.
Generally feeling horribly; Four days later terrible body aches; chills; vomiting and a headache that lasted for 36 hours; Headache; Seven days later, still lethargic and fatigued; fatigue; This is a spontaneous report received from a contactable consumer (patient).   A 58-year-old (non-pregnant) female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: EL9266) via an unspecified route of administration, administered in left arm on 22Feb2021 at 10:30 AM as 1st dose single for covid-19 immunisation. The patient medical history included breast cancer on an unknown date in 2015. The patient had known allergy with penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications included tamoxifen, ergocalciferol (VIT D), calcium,, acetylsalicylic acid (BABY ASPIRIN) and ascorbic acid, chromium, copper, folic acid, inositol, magnesium, manganese, nicotinamide, pantothenic acid, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, vitamin b1 nos, vitamin b12 nos (MULTI VIT) in two weeks of vaccination. On 22Feb2021 (the night of 1st shot vaccination), the patient experienced headache. On 26Feb2021, four days later, the patient experienced terrible body aches, chills, vomiting and a headache that lasted for 36 hours. The patient was generally feeling horribly and seven days later still lethargic and fatigued was continued. The patient did not receive treatment for the events. The patient had not covid tested post vaccination and patient had no covid prior vaccination. The outcome of the events was recovered on an unknown date in 2021. It was reported that patient was recovered with lasting effects.  No follow-up attempts are possible. No further information is expected.
chronic obstructive pulmonary disease exacerbation; viral infection with superimposed pneumonia; viral infection with superimposed pneumonia; This spontaneous report was received from a lawyer and a male patient of unknown age regarding a case in litgation on 30-MAR-2021. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On or about 25-APR-2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dose, route of administration and anatomical location was not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date after receiving zoster vaccine live (ZOSTAVAX), the patient experienced increased shortness of breath, body aches and cough, which was diagnosed as viral infection with superimposed pneumonia and chronic obstructive pulmonary disease exacerbation, which required hospitalization on unspecified dates. As a result and proximate result of zoster vaccine live (ZOSTAVAX) vaccination, patient's symptoms had resulted in sustained severe, permanent and incurable personal injuries not present prior to vaccination, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. At the reporting time, the outcome ofviral infection with superimposed pneumonia and chronic obstructive pulmonary disease exacerbation was considered as not recovered. The reporters considered all the events to be related to Zoster Vaccine Live (ZOSTAVAX).     The reporters considered viral infection with superimposed pneumonia and chronic obstructive pulmonarydisease exacerbation as a disabling events. Upon internal review, the event of pneumonia was determined to be medically significant.
Subsequent to second dose, within a couple days, I felt extreme fatigue and brain fog.  I waited to report or seek medical attention until now - thought I'd get better as I usually do from any ailment but the symptoms persist.
Vac. given 10/30/08 @ 9:35 am.  At 11:30 am: gastric tightness (knot), persistent nausea; extremely swollen, red eyes; persistent feeling of fainting/passing out (hypotension), hoarseness, tightness in lungs and shallow, limited breathing; at 2-2:30 pm, transient pain over both kidney areas.  Saw MD at 4:45 pm in clinic.  Transferred to ER to R/O heart attack; BP continued @ 80's/40's for several more hours.  Discharged 10/31/08 at 1 am with no evidence of heart attack, with low-normal BP.  Swollen eyes resolved after several days.
Patient received Moderna COVID vaccine on 2/8/21 and 3/8/21. On 6/21/22, patient tested positive for COVID an d was prescribed Paxlovid. On 6/27/22, patient admitted to our inpatient facility (med/surg unit) with acute hypoxemic respiratory failure, COVID-19 pneumonia, atrial fibrillation with rapid ventricular response, and acute metabolic encephalopathy. As of today (6/30/22), patient is still admitted in the med/surg unit.
Varicella vaccine given on 9/7/10. Patient returns to clinic with complaint of (R)ight arm pain, itching at the site and a rash. -> Treated with antibiotic (KEFLEX) TYLENOL/MOTRIN.
Patient called the pharmacy with concern about red area excessive swelling and redness at the injection site (size of a grapefruit).  Patient was concerned that the area resembled cellulitis.  By the time she saw the doctor on 2/16/09- swelling & redness substantially reduced.  Physician recommended BENADRYL or CORICIDIN for symptoms.